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Abstract 
Background: Sepsis is a major risk factor for acute respiratory distress syndrome (ARDS). However, there remains a 
paucity of literature examining risk factors for ARDS in septic patients early in their course. This study examined the 
role of early fluid administration and identified other risk factors within the first 6 h of hospital presentation associated 
with developing ARDS in septic patients.
Methods: This was a secondary analysis of septic adult patients presenting to the Emergency Department or being 
admitted for high-risk elective surgery from the multicenter observational cohort study, US Critical Injury and Illness 
trial Group-Lung Injury Prevention Study 1 (USCIITG-LIPS 1, NCT00889772). Multivariable logistic regression was per-
formed to identify potential early risk factors for ARDS. Stratified analysis by shock status was performed to examine 
the association between early fluid administration and ARDS.
Results: Of the 5584 patients in the original study cohort, 2534 (45.4%) met our criteria for sepsis. One hundred and 
fifty-six (6.2%) of these patients developed ARDS during the hospital stay. In multivariable analyses, Acute Physiology 
and Chronic Health Evaluation (APACHE) II score (OR 1.10, 95% CI 1.07–1.13), age (OR 0.97, 95% CI 0.96–0.98), total fluid 
infused in the first 6 h (in liters) (OR 1.15, 95% CI 1.03–1.29), shock (OR 2.57, 95% CI 1.62–4.08), pneumonia as a site of 
infection (OR 2.31, 95% CI 1.59–3.36), pancreatitis (OR 3.86, 95% CI 1.33–11.24), and acute abdomen (OR 3.77, 95% CI 
1.37–10.41) were associated with developing ARDS. In the stratified analysis, total fluid infused in the first 6 h (in liters) 
(OR 1.05, 95% CI 0.87–1.28) was not associated with the development of ARDS in the shock group, while there was an 
association in the non-shock group (OR 1.21, 95% CI 1.05–1.38).
Conclusions: In septic patients, the following risk factors identified within the first 6 h of hospital presentation were 
associated with ARDS: APACHE II score, presence of shock, pulmonary source of infection, pancreatitis, and presence 
of an acute abdomen. In septic patients without shock, the amount of fluid infused during the first 6 h of hospital 
presentation was associated with developing ARDS.
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Background
Acute respiratory distress syndrome (ARDS) is a com-
mon condition encountered in the intensive care unit 
(ICU), with close to 10% of all patients admitted to the 
ICU developing ARDS [1]. Sepsis has long been recog-
nized as a major risk factor for the development of ARDS. 
Prior investigations have reported approximately up to 
40% of ARDS patients also having a diagnosis of sepsis 
[2, 3]. Previous work has described risk factors in septic 
shock patients that are predictive of ARDS, but this work 
has largely focused on patients admitted to the ICU [4]. 
Recent international sepsis guidelines have highlighted 
the importance of early recognition and treatment and 
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have specifically focused on the first 3 and 6 h of care [5]. 
Multiple studies have demonstrated improved mortality 
and outcomes with increased adherence to these guide-
lines [6, 7]. It is likely that during this critical 6-h period 
of initial presentation there are readily identifiable risk 
factors in the sepsis population that predispose them to 
developing ARDS. Despite these observations, literature 
examining risk factors for ARDS in septic patients early 
in their course like in the emergency department remains 
sparse. There have been preliminary data on the epide-
miology of ARDS in septic patients in the emergency 
department, but these studies have been limited by their 
retrospective nature, only including a single center, and 
small sample size [8, 9].
Early fluid administration may be an important mod-
ifiable risk factor for the development of ARDS in sep-
sis patients. There has been recent debate regarding the 
optimal fluid strategy in septic patients. One of the most 
important components of sepsis resuscitation bundles is 
fluid resuscitation. Three recently published sepsis trials 
found that protocolized resuscitation did not perform 
any better than usual or standard care by physicians [10–
12]. The mortality rates in these studies were much lower 
than prior studies, and this has led to speculation that the 
early aggressive volume resuscitation instituted in these 
studies partially explains this observed lower mortal-
ity. On the other hand, there have been several studies 
demonstrating worse outcomes with larger fluid resus-
citation and positive fluid balance during ICU stay in 
septic patients [13–16]. Sepsis is a highly inflamed state, 
with increased capillary permeability. Excessive volume 
administration could lead to increased pulmonary edema 
and subsequent ARDS. In spite of this, the role of vol-
ume resuscitation and developing ARDS during the early 
period of sepsis has not been extensively studied.
In a large multicenter cohort of septic patients, we 
sought to identify risk factors readily detectable during 
the first 6 h of hospital presentation that were associated 
with the development of ARDS and examine the asso-




This was a secondary analysis of a multicenter observa-
tional cohort study, US Critical Injury and Illness trial 
Group-Lung Injury Prevention Study 1 (USCIITG-LIPS 
1, NCT00889772) [17]; patients were enrolled prospec-
tively in 19 hospitals and retrospectively (after hospi-
tal discharge) in three hospitals over a 6-month period, 
beginning in March 2009. The hospitals included both 
community and academic medical centers with 20 of the 
hospitals located in the USA and two hospitals located 
in Turkey. The study was approved by the institutional 
review board at each participating institution. Approval 
was also granted for ancillary studies such as the present 
investigation.
Study patients
The original study included consecutive adult patients 
with one or more study-defined ARDS risk factors admit-
ted to the hospital through the Emergency Department 
or admitted for high-risk elective surgery. This was a sub-
group analysis that included patients with sepsis as an 
ARDS risk factor. These patients were followed during 
their initial hospital stay to assess for the development 
of ARDS. We defined sepsis as those with the presence 
of known or suspected infection with 2 or more sys-
temic inflammatory response syndrome (SIRS) criteria 
or the diagnosis of pneumonia at the time of enrollment. 
Patients with the diagnosis of ARDS at the time of initial 
presentation were excluded.
Data collection
As detailed in the original lung injury prediction score 
(LIPS) study [17], demographics, comorbidities, and clin-
ical variables were collected during the first 6 h of initial 
evaluation. Data were entered into a secure electronic 
database (REDCap).
Outcome
The primary outcome was development of ARDS during 
the hospital stay. ARDS was defined according to the Ber-
lin definition [18]. The Berlin definition was retrospec-
tively applied to the data, as this definition was not yet 
published at the time of the data collection.
Statistical analysis
Continuous data were reported as means and standard 
deviations. Categorical data were reported as counts 
and percentages. As appropriate, Student’s t tests and 
Chi-square tests were used to compare characteris-
tics between the ARDS and non-ARDS groups. Logistic 
regression was performed to examine the association 
of potential risk factors and development of ARDS in 
this sepsis cohort. We a priori hypothesized the follow-
ing risk factors would be associated with ARDS in septic 
patients: Acute Physiology and Chronic Health Evalu-
ation (APACHE) II score, age, total fluid infused during 
first 6 h, presence of shock, race, gender, pneumonia as 
site of infection, and blood product transfusion. Shock 
was defined as presence of hypotension (systolic blood 
pressure <90 mmHg, or decrease of 40 mmHg from base-
line, or mean arterial pressure <65 mmHg) with evidence 
of inadequate tissue perfusion on physical examination 
(altered mental status not explained by other causes 
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other than the hemodynamic status and urine output less 
than 0.5 ml/Kg/min). The definitions of all clinical vari-
ables are available in the online data supplement of the 
original study [17]. Total fluid infused during first 6  h 
was calculated by adding the total amount of crystalloid, 
colloid, and other infusions received during that time 
period. We additionally examined the risk factors identi-
fied in the original LIPS study that were associated with 
ARDS [17].
We performed univariable analysis of the risk factors 
identified in the original LIPS study. Risk factors with a p 
value <0.2 were then entered into a multivariable model. 
Additionally, using a forced entry strategy, the a priori 
hypothesized risk factors were also entered into the mul-
tivariable model. We then used stepwise backward elimi-
nation, retaining variables with a p value <0.2, to select 
the optimal model. Variables in which less than 1% of the 
study population had the variable present, or in which 
>30% of the values were missing were excluded from 
analysis. We additionally hypothesized that the asso-
ciation between total amount of fluid infused during the 
first 6 h and development of ARDS would differ between 
the shock and non-shock groups and thus performed a 
stratified analysis by shock status.
Odds ratio (OR) and 95% CI were reported. Imputation 
with mean value was used to analyze continuous vari-
ables with missing data. Missing indicator method was 
used to analyze categorical variables with missing data. 
The following variables had >5% missing data: total fluid 
infused during first 6  h (28%), alcohol use (10%), blood 
product transfusion (23%), obesity (20%), tobacco use 
(7%), and FIO2 >0.35 (8%). Sensitivity analysis was per-
formed using complete case analysis. All analyses were 
performed using SAS version 9.4 (SAS Institute, Cary, 
NC). In the final model, a p value <0.05 was considered 
significant.
Results
A total of 5584 patients were included in the original 
LIPS study cohort (309 of these patients were enrolled 
retrospectively). Out of 5584, 2534 patients (45.4%) in 
the original study cohort met our predefined criteria 
for sepsis and were analyzed (Fig.  1). One hundred and 
fifty-six (6.2%) of these patients developed ARDS dur-
ing the hospital stay. Mean time to development of 
ARDS was 4.5  ±  5.3  days, with approximately 50% of 
the cases occurring in the first 2 days of hospitalization, 
and 80% occurring within 5  days. 1209 (47.7%) of the 
sepsis cohort were admitted to the ICU, and 170 (6.7%) 
died during their in-hospital stay. Of the patients that 
developed ARDS, 54 (34.6%) died, while 116 (4.9%) of 
the patients that did not develop ARDS died. The mean 
hospital length of stay for septic patients with ARDS 
was 19.1 ±  16.2  days and for those without ARDS was 
7.6  ±  8.1  days (p  <  0.001). Patient characteristics are 
listed in Table 1.
In univariable analysis, APACHE II score, age, total 
fluid infused during first 6 h, shock, race, gender, pneu-
monia, blood product transfusion, aspiration, pancrea-
titis, acute abdomen, tachypnea, hypoxemia, and FIO2 
>0.35 were all associated with the increased odds of 
development of ARDS, while the diagnosis of diabe-
tes mellitus was found to be protective against ARDS 
(Table 2).
The final multivariable model is demonstrated in 
Table 3. APACHE II score (OR 1.10, 95% CI 1.07–1.13), 
age (OR 0.97, 95% CI 0.96–0.98), total fluid infused in 
the first 6 h (in liters) (OR 1.15, 95% CI 1.03–1.29), shock 
(OR 2.57, 95% CI 1.62–4.08), pneumonia as a site of 
infection (OR 2.31, 95% CI 1.59–3.36), pancreatitis (OR 
3.86, 95% CI 1.33–11.24), and acute abdomen (OR 3.77, 
95% CI 1.37–10.41) were all associated with the develop-
ment of ARDS. We performed a sensitivity analysis with 
complete case analysis that yielded similar results (Addi-
tional file 1: Table S1).
We also observed that during the first 6  h of hospi-
tal presentation the incidence of ARDS increased with 
increasing fluid administration (Fig.  2). The stratified 
analysis according to the presence of shock revealed that 
the relationship between amount of fluid infused in first 
6 h and the development of ARDS was not present within 
the subgroup of patients with shock (OR 1.05, 95% CI 
0.87–1.28) (Table 4). This association was still present in 
the non-shock group (OR 1.21, 95% CI 1.05–1.38).
Discussion
In this large cohort of patients with sepsis and pneumo-
nia, we found that the rate of developing ARDS was low. 
Although only 6% of at-risk patients developed ARDS, 
Fig. 1 Patient selection diagram with outcomes
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mortality was significantly higher in those who devel-
oped ARDS. We found that APACHE II score, age, higher 
volume of early fluid administration, pulmonary source 
of sepsis, shock, pancreatitis, and acute abdomen were 
all associated with the development of ARDS. Of these 
exposures, fluid administration appears to be the only 
potentially modifiable exposure.
Our results highlight the role of the amount of fluid 
administered to septic patients during the first 6  h of 
care and the development of ARDS. Other studies sup-
port our findings that increased fluid administration 
may be associated with the development of ARDS. Jia 
et  al. [19] demonstrated that a positive fluid balance 
during the first 48 h of mechanically ventilated patients 
is associated with the development of ARDS. In addi-
tion, after initial resuscitation, conservative fluid-man-
agement strategies compared to liberal strategies have 
increased days alive and off the ventilator in patients 
Table 1 Characteristics of patients in the sepsis cohort
Data are presented as mean ± SD or n (%) unless otherwise indicated
APACHE Acute Physiology and Chronic Health Evaluation, BMI body mass index, RR respiratory rate
Total (n = 2534) ARDS (n = 156) No ARDS (n = 2378) p value
APACHE II 11.7 ± 6.4 16.3 ± 7.4 11.4 ± 6.2 <0.001
Age (years) 58.5 ± 18.8 54.9 ± 17.3 58.8 ± 18.9 0.01
Total fluid infused during first 6 h (L) 1.49 ± 1.51 2.54 ± 2.31 1.41 ± 1.42 <0.001
Race 0.04
 White 1448 (59.2) 97 (63.8) 1351 (58.9)
 Black 724 (29.6) 31 (20.4) 693 (30.2)
 Asian 35 (1.4) 3 (2.0) 32 (1.4)
 Other 240 (9.8) 21 (13.8) 219 (9.5)
Shock 234 (9.23) 44 (28.2) 190 (8.0) <0.001
Male 1298 (51.2) 94 (60.3) 1204 (50.6) 0.02
Pneumonia as site of infection 1234 (48.7) 91 (58.33) 1143 (48.1) 0.01
Alcohol use 596 (26.0) 41 (29.3) 555 (25.8) 0.36
Blood product transfusion 51 (2.6) 10 (8.6) 41 (2.2) <0.001
Aspiration 103 (4.1) 15 (9.6) 88 (3.7) <0.001
Pancreatitis 24 (1.0) 5 (3.2) 19 (0.8) 0.003
Thoracic surgery 6 (0.2) 0 (0.0) 6 (0.3) 0.53
Spine surgery 3 (0.1) 2 (1.3) 1 (0.0) <0.001
Acute abdomen 42 (1.7) 6 (3.9) 36 (1.5) 0.03
Cardiac surgery 3 (0.1) 0 (0.0) 3 (0.1) 0.66
Aortic surgery 3 (0.1) 0 (0.0) 3 (0.1) 0.66
Lung contusion 2 (0.1) 0 (0.0) 2 (0.1) 0.72
Near drowning 0 (0) 0 0 NA
Brain injury 11 (0.4) 3 (1.9) 8 (0.34) 0.004
Smoke inhalation 4 (0.2) 1 (0.6) 3 (0.1) 0.12
Long-bone fractures 5 (0.2) 3 (1.9) 2 (0.1) <0.001
Obesity (BMI > 30) 598 (23.6) 44 (28.2) 554 (23.3) 0.16
Chemotherapy 131 (5.2) 10 (6.4) 121 (5.1) 0.47
Diabetes mellitus 733 (28.9) 33 (21.1) 700 (29.4) 0.03
Tobacco use 0.83
 Never 1177 (49.7) 73 (51.4) 1104 (49.6)
 Former 652 (27.6) 36 (25.4) 616 (27.7)
 Current 538 (22.7) 33 (23.3) 505 (22.7)
Emergency surgery 41 (1.6) 5 (3.2) 36 (1.5) 0.10
Tachypnea (RR > 30) 239 (9.7) 30 (20.0) 209 (9.0) <0.001
Hypoxemia (SpO2 < 95%) 861 (34.6) 68 (44.2) 793 (34.0) 0.01
FIO2 >0.35 395 (17.0) 61 (41.2) 334 (15.4) <0.001
Hypoalbuminemia 695 (54.9) 64 (74.4) 631 (53.4) <0.001
Acidosis (pH < 7.35) 231 (42.5) 50 (55.6) 181 (40.0) 0.006
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with established ARDS, many of whom had sepsis as a 
risk factor [20]. Multiple studies have demonstrated that 
increasing extravascular lung water is associated with 
mortality in ARDS patients [21–23]. A positive fluid bal-
ance has also been associated with increased mortality 
in septic shock patients [13].
Conversely, early resuscitation in sepsis has been 
shown to decrease inflammatory markers [24]. There-
fore, fluid resuscitation during this early phase of sepsis 
may actually be beneficial and decrease the risk of ARDS 
by limiting the inflammatory cascade. One study dem-
onstrated in septic patients with the diagnosis of ARDS 
aggressive fluid resuscitation in the first 6 h followed by 
conservative fluid management in the next 7 days was the 
optimal fluid therapy in terms of mortality [25]. A prior 
investigation demonstrated that inadequate resuscita-
tion for patients in septic shock was an independent risk 
factor for ARDS [4]. Another study demonstrated that 
total volume of fluid infused during the first 24 h of care 
of severe sepsis and septic shock patients did not increase 
risk of ARDS [26].
Table 2 Univariable logistic regression of early risk factors 
for ARDS in sepsis cohort
For continuous variables, the odds ratio indicates the increased odds of ARDS for 
a 1-unit increase of the variable
APACHE Acute Physiology and Chronic Health Evaluation, BMI body mass index, 
RR respiratory rate
Odds ratio (95% CI) p value
APACHE II 1.11 (1.08–1.13) <0.001
Age (years) 0.99 (0.98–1.0) 0.01
Total fluid infused during first 6 h (L) 1.40 (1.28–1.54) <0.001
Race
 White Reference Reference
 Black 0.62 (0.41–0.94) 0.02
 Asian 1.31 (0.39–4.34) 0.59
 Other 1.34 (0.82–2.19) 0.25
Shock 4.52 (3.10–6.61) <0.001
Gender (male) 1.48 (1.06–2.06) 0.02
Pneumonia as site of infection 1.51 (1.09–2.10) 0.01
Alcohol use 1.19 (0.82–1.74) 0.36
Blood product transfusion 4.10 (2.00–8.41) <0.001
Aspiration 2.77 (1.56–4.91) <0.001
Pancreatitis 4.11 (1.51–11.16) 0.003
Acute abdomen 2.60 (1.08–6.27) 0.03
Obesity (BMI > 30) 1.29 (0.90–1.86) 0.16
Chemotherapy 1.28 (0.66–2.49) 0.47
Diabetes mellitus 0.64 (0.43–0.95) 0.03
Tobacco use
 Never Reference Reference
 Former 0.88 (0.59–1.33) 0.56
 Current 0.99 (0.65–1.51) 0.81
Emergency surgery 2.16 (0.83–5.57) 0.11
Tachypnea (RR > 30) 2.52 (1.65–3.86) <0.001
Hypoxemia (SpO2 < 95%) 1.54 (1.11–2.14) 0.01
FIO2 >0.35 3.86 (2.72–5.46) <0.001
Table 3 Multivariable logistic regression of  early risk fac-
tors for ARDS in sepsis cohort
For continuous variables, the odds ratio indicates the increased odds of ARDS for 
a 1-unit increase in the variable
APACHE Acute Physiology and Chronic Health Evaluation, RR respiratory rate
Odds ratio (95% CI) p value
APACHE II 1.10 (1.07–1.13) <0.001
Age (years) 0.97 (0.96–0.98) <0.001
Total fluid infused during first 6 h (L) 1.15 (1.03–1.29) 0.01
Shock 2.57 (1.62–4.08) <0.001
Gender (male) 1.30 (0.92–1.85) 0.14
Race
 White Reference Reference
 Black 0.56 (0.36–0.87) 0.08
 Asian 1.14 (0.32–4.11) 0.58
 Other 1.14 (0.66–1.96) 0.29
Pneumonia as site of infection 2.31 (1.59–3.36) <0.001
Pancreatitis 3.86 (1.33–11.24) 0.01
Acute abdomen 3.77 (1.37–10.41) 0.01
Diabetes mellitus 0.74 (0.48–1.12) 0.16
Tachypnea (RR > 30) 1.41 (1.00–1.97) 0.05
Fig. 2 Frequency of acute respiratory distress syndrome (ARDS) 
development according to amount of fluid administered during the 
first 6 h of hospital presentation
Table 4 Shock subgroup analysis: multivariable analysis 
of total volume in first 6 h and the development of ARDS
The odds ratio indicates the increased odds of ARDS for a 1-l increase in volume 
of fluids administered
Odds ratio (95% CI) p value
Shock 1.05 (0.87–1.28) 0.60
No shock 1.21 (1.05–1.38) 0.01
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Our stratified analysis showed that fluid administration 
during the first 6 h was not significantly associated with 
ARDS in the subgroup of patients with shock. However, 
we did demonstrate that the association between amount 
of fluid infused in the first 6  h and the development of 
ARDS was present in patients without shock. This may 
suggest that septic patients without shock are at the high-
est risk of ARDS with early excessive fluid administration. 
It is important to note that only 9% of our patients had 
shock. Larger size studies with sufficient power are nec-
essary to examine this issue. Interestingly, this phenom-
enon has also been observed in patients with severe blunt 
trauma. A multicenter prospective study demonstrated 
that blunt trauma patients with prehospital hypotension 
and higher crystalloid infusion did not have an increased 
incidence of ARDS, while blunt trauma patients without 
prehospital hypotension and higher crystalloid infusion 
did have a higher incidence of ARDS [27].
Despite multiple randomized control trials comparing 
different early resuscitation protocols for septic patients, 
this relationship between early fluid resuscitation in sep-
tic patients and ARDS has not been well studied. Unfor-
tunately, none of these trials specifically looked at ARDS 
as an outcome. The original early goal-directed therapy 
(EGDT) trial did not measure the incidence of ARDS 
directly, but did report the need for mechanical ventila-
tion [28]. The patients randomized to the EGDT group 
received more fluids in the first 6  h and had a signifi-
cantly decreased requirement of mechanical ventilation. 
This suggests in that patient population early aggressive 
fluid administration was not associated with respiratory 
impairment and in fact was associated with improved 
respiratory outcomes. Our results do not contradict 
those findings. The patients in the EGDT study were 
considerably sicker than our cohort. They had an initial 
APACHE score of 21 and an overall mortality of 37%. As 
we have demonstrated in our study, it is in the less sick 
patients without shock in which we observed the associa-
tion of increased early fluids and ARDS. The subsequent 
three sepsis trials comparing standard care to EGDT did 
not demonstrate a significant association between EGDT 
and respiratory outcomes [10–12]. This may be due to 
the fact that there was not a large difference in amount 
of fluid received between the control and interventional 
arms. In the PROMISE and ARISE trials, the difference 
in the amount of fluids given in the first 6 h between the 
control and intervention groups was between 200 and 
250 cc. However, in the PROCESS trial there were three 
arms: EGDT, another protocolized resuscitation, and 
standard care. The standard care group had a significantly 
lower volume infused in the first 6 h: 2.3L (standard care) 
versus 2.8L (EGDT) and 3.3L (other protocolized resusci-
tation) (p < 0.001) and had a trend toward less respiratory 
failure. At this point, it is unclear what the optimal fluid 
strategy is during the early phase of sepsis to prevent 
ARDS. It likely depends on several factors including 
severity of illness and hemodynamic status.
Our findings are also consistent with prior investiga-
tions that demonstrated severity of illness, pneumonia as a 
source of infection, and shock at presentation as risk factors 
for ARDS in septic patients [8]. We additionally found that 
pancreatitis and acute abdomen were risk factors for ARDS 
in this cohort. This is not surprising, given that lung and 
abdomen have been identified as the most frequent sources 
of infection in patients with ARDS [29]. The contribution 
of pulmonary sepsis to ARDS is likely multifactorial. Sep-
tic patients with pneumonia have a direct lung injury from 
the pneumonia itself and then indirect lung injury from the 
sepsis inflammatory cascade, which can both lead to ARDS. 
It has also long been known that ARDS is a major compli-
cation of severe pancreatitis. ARDS has been reported to be 
the major cause of death of acute pancreatitis patients that 
die within one week of presentation [30, 31].
Blood product administration is a known risk fac-
tor for lung injury and progression to ARDS in critically 
ill patients [19, 32–34]. Our study found an association 
with ARDS in univariable analysis, but our multivariable 
analysis did not. We were likely underpowered to demon-
strate such an association, since only 2.6% of our patients 
received blood products. In contrast to our results, Isci-
men et al. [4] found that blood product transfusion in the 
septic shock population independently predicted ARDS. 
Their study differed from ours in that it only evaluated 
patients in septic shock, and over 50% of the patients 
received some blood product transfusion.
Our study has several strengths. This was a large mul-
ticenter study, and the majority of data were prospec-
tively collected. Additionally, our study is generalizable 
to patients with the entire spectrum of sepsis, since our 
study included sepsis and septic shock. Our study also 
has some limitations. First, we did not collect data on 
some important risk factors that have been associated 
with ARDS in sepsis including time to antibiotics and 
lactate level. Second, we have incomplete data on some 
of the covariates. We dealt with the missing data using 
established epidemiologic methods. We also performed a 
sensitivity analysis with complete case analysis and found 
that our results were similar. Third, there is risk for mis-
classification from medical chart review. This risk was 
reduced since the vast majority of these patients were 
enrolled prospectively with close follow-up. Fourth, there 
is the limitation that most ARDS investigations share 
regarding the reproducibility of diagnosis of ARDS. In 
order to mitigate this limitation, mandatory structured 
training in ARDS assessment was instituted and site-
principal investigators were responsible for ensuring 
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quality. Finally, we are able to demonstrate association, 
but not demonstrate causality. Future studies, includ-
ing advanced adjustment techniques, are warranted to 
confirm the relationship between initial fluid adminis-
tration and ARDS development. However, because the 
application of propensity score methods for continuous 
exposures is less well developed than their use for binary 
exposures, we adjusted for potential confounders using 
multivariable logistic regression models [35].
Conclusions
In septic patients, we demonstrated that the follow-
ing variables present upon initial hospital presentation: 
Severity of illness, age, pulmonary source of sepsis, pres-
ence of shock, pancreatitis, and acute abdomen were 
associated with developing ARDS. In septic patients 
without shock, we also identified another important 
association between a potentially modifiable risk factor, 
the amount of fluid infused in the first 6 h, and the devel-
opment of ARDS. Future investigations should focus on 
determining the optimal early resuscitation strategies for 
septic patients based on severity of sepsis and examine 
the outcome of ARDS.
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